Gufic Biosciences Limited
GUFICBIO · NSE · ₹420 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Gufic Biosciences Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 16.6%; Net profit was ₹22.31 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹261 cr | +16.6% | Net profit: ₹22 cr | +70.7% | 8.6% | Company filing source |
| Mar 2026 | Revenue: ₹252 cr | +22.8% | Net profit: ₹22 cr | +183.6% | 8.7% | Company filing source |
| Dec 2025 | Revenue: ₹231 cr | — | Net profit: ₹12 cr | — | 5.4% | Company filing source |
| Sep 2025 | Revenue: ₹237 cr | — | Net profit: ₹17 cr | — | 7.1% | Company filing source |
| Jun 2025 | Revenue: ₹224 cr | +10.3% | Net profit: ₹13 cr | -37.3% | 5.8% | Company filing source |
| Mar 2025 | Revenue: ₹205 cr | — | Net profit: ₹8 cr | — | 3.8% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Jayesh Pannalal Choksi 24.6%Zircon Teconica Private Limited 20.5%Gufic Private Limited 10.2%Vipula Jayesh Choksi 10.0%Pranav Jayesh Choksi 7.2%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company. Gufic Biosciences Limited has informed the Exchange about the intimation under Regula…
29 Sep 2026 · document
- Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015…
28 Sep 2026 · document
- General Updates. Gufic Biosciences Limited has informed the Exchange about Intimation of Environmental, Social and Governance ( ESG ) Rating…
28 Sep 2026 · document
- General Updates. Gufic Biosciences Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requiremen…
24 Sep 2026 · document
- Gufic Biosciences Limited has informed the Exchange about Credit Rating…
08 Sep 2026 · document
- Shareholders meeting. Gufic Biosciences Limited has submitted the Exchange a copy of Scrutinizers report and voting results of 42nd Annual General Meeting held …
07 Sep 2026 · document
- Shareholders meeting. Gufic Biosciences Limited has informed the Exchange regarding Proceedings of 42nd Annual General Meeting held on September 04, 2026…
04 Sep 2026 · document
- General Updates. Gufic Biosciences Limited has informed the Exchange about Promotion and Change in Designation of Senior Management Personnel…
02 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time